Attached files
file | filename |
---|---|
EX-32 - CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE - SCIENTIFIC INDUSTRIES INC | exh32.htm |
10-Q - 10-Q - SCIENTIFIC INDUSTRIES INC | a12312010q.htm |
Exhibit 31.0
CERTIFICATION PURSUANT TO SECTION 302
OF THE SARBANES-OXLEY ACT
I, Helena R. Santos, certify that:
1.
|
I have reviewed this Quarterly Report on Form 10-Q of Scientific
Industries, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue
statement of a material fact or omit to state a material fact
necessary to make the statements made, in light of the
circumstances under which such statements were made, not misleading
with respect to the period covered by this report;
|
3.
|
Based on my knowledge, the financial statements, and other
financial information included in this report, fairly present in
all material respects the financial condition, results of
operations and cash flows of the registrant as of, and for, the
periods presented in this report;
|
4.
|
I am responsible for establishing and maintaining disclosure
controls and procedures (as defined in Securities Exchange Act
Rules 13a-15(e) and 15d-15(e)) and internal control over financial
reporting (as defined in Exchange Act Rules 13a-15(f) and
15d-15(f)) for the registrant and have:
|
a)
|
Designed such disclosure controls and procedures, or caused such
disclosure controls and procedures to be designed under my
supervision, to ensure that material information relating to the
registrant, including its consolidated subsidiaries, is made known
to me by others within those entities, particularly during the
period in which this report is being prepared;
|
b)
|
Designed such internal control over financial reporting, or caused
such internal control over financial reporting to be designed under
my supervision, to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of financial
statements for external purpose in accordance with generally
accepted accounting principles;
|
c)
|
Evaluated the effectiveness of the registrant’s disclosure
controls and procedures, and presented in this report my
conclusions about the effectiveness of the disclosure controls and
procedures, as of the end of the period covered by this report
based on such evaluation; and
|
d)
|
Disclosed in this report any change in the registrant’s
internal control over financial reporting (that occurred during the
registrant’s most recent fiscal quarter (the
registrant’s fourth fiscal quarter) that has materially
affected, or is reasonable likely to materially affect, the
registrant’s internal control over financial reporting;
and
|
5.
|
I have disclosed, based on my most recent evaluation of internal
control over financial reporting, to the registrant’s
auditors and the audit committee of the registrant’s Board of
Directors (or persons performing the equivalent
functions);
|
a)
|
All significant deficiencies and material weaknesses in the design
or operation of internal control over financial reporting which are
reasonably likely to adversely affect the registrant’s
ability to record, process, summarize and report financial
information; and
|
b)
|
Any fraud, whether or not material, that involves management or
other employees who have a significant role in the
registrant’s internal control over financial
reporting.
|
|
Scientific Industries, Inc.
|
||
|
|
|
|
|
|
|
|
Date: February 23, 2021
|
By:
|
/s/ Helena R. Santos
|
|
|
|
Helena R. Santos
|
|
|
|
Chief Executive Officer and
|
|
|
|
Chief Financial Officer
|
|